CIUFFREDA, LIBERO
 Distribuzione geografica
Continente #
NA - Nord America 763
EU - Europa 339
AS - Asia 166
AF - Africa 6
OC - Oceania 5
SA - Sud America 5
Totale 1.284
Nazione #
US - Stati Uniti d'America 755
IT - Italia 142
CN - Cina 110
SE - Svezia 50
IE - Irlanda 45
GB - Regno Unito 22
FR - Francia 20
DE - Germania 13
VN - Vietnam 13
FI - Finlandia 12
CA - Canada 8
HK - Hong Kong 8
PL - Polonia 8
IN - India 7
BE - Belgio 6
KR - Corea 6
NL - Olanda 6
AU - Australia 5
IR - Iran 5
JP - Giappone 5
HU - Ungheria 4
SG - Singapore 4
UA - Ucraina 4
SN - Senegal 3
TW - Taiwan 3
BR - Brasile 2
CH - Svizzera 2
CL - Cile 2
DK - Danimarca 2
IL - Israele 2
NG - Nigeria 2
AL - Albania 1
AM - Armenia 1
AR - Argentina 1
GR - Grecia 1
NO - Norvegia 1
PK - Pakistan 1
TH - Thailandia 1
ZW - Zimbabwe 1
Totale 1.284
Città #
Chandler 101
Fairfield 78
Houston 53
Ashburn 50
Dublin 45
Woodbridge 43
Beijing 42
Ann Arbor 36
Cambridge 33
Seattle 33
Torino 32
Wilmington 25
Nyköping 24
Dearborn 18
New York 14
Pisa 14
Turin 14
Villeurbanne 14
Princeton 13
Medford 12
Shanghai 10
San Diego 9
Hong Kong 8
Warsaw 8
Guangzhou 7
Jacksonville 7
Boardman 6
Brussels 6
Dong Ket 6
Fremont 6
Lanzhou 5
Oxford 5
Tokyo 5
Pune 4
Singapore 4
Verona 4
West Jordan 4
Wuhan 4
Boston 3
Caserta 3
Chengdu 3
Nanjing 3
Norwalk 3
Ottawa 3
Taipei 3
Upper Marlboro 3
Abuja 2
Alba 2
Amsterdam 2
Atlanta 2
Budapest 2
Changchun 2
Desio 2
Genova 2
Hebei 2
Hefei 2
Helsinki 2
Jerusalem 2
Kish 2
Kunming 2
Las Vegas 2
Leawood 2
Leeuwarden 2
London 2
Los Angeles 2
Milan 2
Mutterstadt 2
Newcastle 2
Ningbo 2
Nuremberg 2
Phoenix 2
Salt Lake City 2
San Mateo 2
Santiago 2
Serra 2
Tianjin 2
Toronto 2
Venezia 2
Washington 2
Aarhus 1
Aradeo 1
Basel 1
Bedwas 1
Berlin 1
Borgaro Torinese 1
Bovisio Masciago 1
Bristol 1
Buffalo 1
Cairate 1
Calatabiano 1
Canosa Di Puglia 1
Changsha 1
Chicago 1
Collegno 1
Düsseldorf 1
Fazal 1
Ferrara 1
Flanders 1
Florence 1
Hangzhou 1
Totale 913
Nome #
Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study) 230
Postnatal risk factors for testicular cancer: The EPSAM case-control study 175
Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial 165
Subfertility and risk of testicular cancer in the EPSAM case-control study 149
Thymic stromal lymphopoietin in human pancreatic ductal adenocarcinoma: Expression and prognostic significance 109
Baldness and testicular cancer: The EPSAM case-control study 107
Pilot clinical trial on the efficacy of prophylactic use of vitamin K 1-based cream (Vigorskin) to prevent cetuximab-induced skin rash in patients with metastatic colorectal cancer 72
Final results of the SENECA (SEcond line NintEdanib in non-small cell lung CAncer) trial 71
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme 51
Quality of life among germ-cell testicular cancer survivors: The effect of time since cancer diagnosis 51
Current therapeutic strategies for advanced pancreatic cancer: A review for clinicians 45
Syndrome of inappropriate anti-diuretic hormone secretion in cancer patients: results of the first multicenter Italian study 36
GENDER-SPECIFIC SIDE EFFECTS OF CHEMOTHERAPY IN PANCREATIC CANCER PATIENTS 31
Colorectal cancer chemotherapy: can sex-specific disparities impact on drug toxicities? 19
Molecular Subtypes of Extra-pulmonary Neuroendocrine Carcinomas Identified by the Expression of Neuroendocrine Lineage-Specific Transcription Factors 9
Evaluation of the control of pain in patients with bone metastasis undergoing medical treatment with bisphosphonates 5
Evaluation of nausea and vomiting in oncology patients treated with chemotherapy: a retrospective study 3
Procalcitonin as a predictive marker of infections in chemoinduced neutropenia 2
Totale 1.330
Categoria #
all - tutte 3.781
article - articoli 0
book - libri 0
conference - conferenze 55
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.836


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201952 0 0 0 0 0 0 0 0 0 0 37 15
2019/2020264 15 10 12 34 20 40 26 25 32 21 20 9
2020/2021188 13 19 22 12 14 15 13 11 15 19 6 29
2021/2022201 12 8 10 15 12 10 8 16 10 18 60 22
2022/2023281 37 29 6 23 21 70 18 13 33 7 17 7
2023/2024153 15 31 9 7 8 38 10 16 7 12 0 0
Totale 1.330